Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201
- PMID: 12960598
- DOI: 10.1097/00006231-200309000-00007
Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201
Abstract
The aim of this study was to assess the influence of incremental nitroglycerin infusion (NTG+Inf) on the myocardial uptake of 99mTc-tetrofosmin (TF) in order to determine whether nitrates enhance the detection of viable myocardium with TF in patients with coronary artery disease (CAD) and left ventricular dysfunction. Fifty patients (39 males, 11 females; 54 +/- 11 years) with previous myocardial infarction and left ventricular dysfunction, who had been referred for coronary revascularization procedures, were studied. Myocardial single-photon emission tomography (SPET) images were obtained 1 h after injection of 750 MBq TF at baseline and after NTG+Inf, using a 2 day protocol. NTG+Inf was performed starting at 0.4 microg x kg(-1) x min(-1), with equal increments every 5 min up to 2 microg x kg(-1) x min(-1). Within 1 week of the TF study, rest-redistribution (R-RD) 201Tl SPET was performed after the injection of 111 MBq 201Tl. For each study, quantitative analysis was performed in 17 segments. Viability was defined as the presence of tracer uptake of > 50% of the peak activity on baseline studies or reversibility. There was significant correlation between quantitative regional RD 201Tl activity and TF activity after NTG+Inf (r = 0.90, P < 0.001). Of the 131 segments with severely reduced tracer uptake on resting TF images, 34 (26%) were reversible, showing increased tracer uptake after NTG+Inf (from 41%+/-7% to 57%+/-12% of peak activity; P < 0.001). All reversible segments after NTG+Inf had viability criteria on 201Tl studies. There was 95% concordance between TF with NTG+Inf and RD 201Tl imaging with regard to the presence of myocardial viability. We conclude that TF imaging with incremental NTG+Inf improves the detection of ischaemic but viable myocardium, correlating with the viability criteria observed on 201Tl studies. When the advantages of TF imaging are considered, rest TF imaging with NTG+Inf may be a practical diagnostic protocol in patients with CAD and left ventricular dysfunction who are being considered for revascularization.
2003 Lippincott Williams & Wilkins
Similar articles
-
Comparison between rest technetium-99m-tetrofosmin and rest-redistribution thallium-201 SPECT in stable patients with healed myocardial infarction.Nucl Med Commun. 2001 Dec;22(12):1317-24. doi: 10.1097/00006231-200112000-00007. Nucl Med Commun. 2001. PMID: 11711902
-
Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.Eur J Nucl Med. 1997 Jul;24(7):767-73. doi: 10.1007/BF00879665. Eur J Nucl Med. 1997. PMID: 9211763
-
Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.J Nucl Cardiol. 1998 Jan-Feb;5(1):56-63. doi: 10.1016/s1071-3581(98)80011-1. J Nucl Cardiol. 1998. PMID: 9504874 Clinical Trial.
-
Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?Clin Cardiol. 1998 Apr;21(4):235-42. doi: 10.1002/clc.4960210402. Clin Cardiol. 1998. PMID: 9562932 Free PMC article. Review.
-
The noninvasive assessment of myocardial viability.Clin Cardiol. 1993 Jul;16(7):531-8. doi: 10.1002/clc.4960160704. Clin Cardiol. 1993. PMID: 8348761 Review.
Cited by
-
Effects of nitroglycerine on coronary flow velocity before and during adenosine provocation.Cardiovasc Ultrasound. 2016 Dec 6;14(1):48. doi: 10.1186/s12947-016-0091-2. Cardiovasc Ultrasound. 2016. PMID: 27919286 Free PMC article.
-
Could myocardial viability be related to left ventricular dyssynchrony? Simultaneous evaluation by gated SPECT-MPI.J Nucl Cardiol. 2020 Aug;27(4):1158-1167. doi: 10.1007/s12350-020-02047-x. Epub 2020 Apr 3. J Nucl Cardiol. 2020. PMID: 32246407
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous